Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development
In the midst of the ongoing COVID-19 coronavirus pandemic, influenza virus remains a major threat to public health due to its potential to cause epidemics and pandemics with significant human mortality. Cases of H7N9 human infections emerged in eastern China in 2013 and immediately raised pandemic c...
Main Authors: | Peter Pushko, Irina Tretyakova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/12/5/518 |
Similar Items
-
Virus-like Particle Vaccines: A Prospective Panacea Against an Avian Influenza Panzootic
by: Nathaniel Nyakaat Ninyio, et al.
Published: (2020-11-01) -
Influenza A Viruses in Whistling Ducks (Subfamily Dendrocygninae)
by: Deborah L. Carter, et al.
Published: (2021-01-01) -
Modular vaccine platform based on the norovirus-like particle
by: Vili Lampinen, et al.
Published: (2021-01-01) -
Two Live Attenuated Vaccines against Recent Low–and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in Ferrets
by: Larisa Rudenko, et al.
Published: (2018-11-01) -
Public knowledge on influenza and influenza vaccines
by: Adrianna Gorecka, et al.
Published: (2021-08-01)